Wang, Xiuli http://orcid.org/0000-0001-5964-4327
Dong, Zhenyuan
Awuah, Dennis http://orcid.org/0000-0002-4295-5599
Chang, Wen-Chung
Cheng, Wesley A. http://orcid.org/0000-0001-9131-8556
Vyas, Vibhuti
Cha, Soung-Chul
Anderson, Aaron J. http://orcid.org/0000-0003-0791-9717
Zhang, Tiantian
Wang, Zhe
Szymura, Szymon J.
Kuang, Benjamin Z.
Clark, Mary C. http://orcid.org/0000-0003-1672-2684
Aldoss, Ibrahim
Forman, Stephen J. http://orcid.org/0000-0002-2803-4152
Kwak, Larry W. http://orcid.org/0000-0002-1884-5349
Qin, Hong
Funding for this research was provided by:
Leukemia and Lymphoma Society (SCOR 7000-18)
U.S. Department of Defense (CA170783)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA033572)
Toni Stephenson Lymphoma Center, City of Hope National Medical Center
Article History
Received: 20 May 2021
Revised: 4 November 2021
Accepted: 15 November 2021
First Online: 18 January 2022
Competing interests
: Sources of support include the National Cancer Institute of the National Institutes of Health (P30CA033572) supporting the Small Animal Imaging Core, National Cancer Institute Lymphoma SPORE (PI: L.W.K.), Leukemia and Lymphoma Society Mantle cell lymphoma Research Initiative (SCOR 7000-18; PI: L.W.K.; Project Leaders: S.J.F.; X.W.), Department of Defense (CA170783, PI: L.W.K.). X.W. is a paid consultant for Pepromene Bio, Inc.; L.W.K. and H.Q. are paid consultants and have equity in Pepromene Bio, Inc. The other authors report no disclosures.